Search Results - "Ma, Qiulan"
-
1
Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer's disease
Published in Drug delivery (2018)“…Alzheimer's disease is a neurodegenerative disorder mainly characterized by β-amyloid deposit and tau hyperphosphorylation with no curative treatments…”
Get full text
Journal Article -
2
The novel omega‐6 fatty acid docosapentaenoic acid positively modulates brain innate immune response for resolving neuroinflammation at early and late stages of humanized APOE‐based Alzheimer’s disease models: Nonhuman/Target identification and validation studies: Inflammation and innate immunity
Published in Alzheimer's & dementia (01-12-2020)“…Abstract Background Neuroinflammation has been well established to play a crucial role in the pathogenesis and progression of Alzheimer’s disease (AD), and…”
Get full text
Journal Article -
3
The novel omega‐6 fatty acid docosapentaenoic acid positively modulates brain innate immune response for resolving neuroinflammation at early and late stages of humanized APOE‐based Alzheimer’s disease models
Published in Alzheimer's & dementia (01-12-2020)“…Background Neuroinflammation has been well established to play a crucial role in the pathogenesis and progression of Alzheimer’s disease (AD), and strong…”
Get full text
Journal Article -
4
P4‐683: OMEGA‐6 FATTY ACIDS AS A NOVEL IMMUNOTHERAPEUTIC APPROACH FOR THE TREATMENT OF ALZHEIMER'S DISEASE
Published in Alzheimer's & dementia (01-07-2019)Get full text
Journal Article -
5
OMEGA-6 FATTY ACIDS AS A NOVEL IMMUNOTHERAPEUTIC APPROACH FOR THE TREATMENT OF ALZHEIMER’S DISEASE
Published in Alzheimer's & dementia (01-07-2019)Get full text
Journal Article -
6
GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals
Published in Neurobiology of disease (01-02-2009)“…Abstract The dysregulation of glycogen synthase kinase-3 (GSK3) has been implicated in Alzheimer disease (AD) pathogenesis and in Aβ-induced neurotoxicity,…”
Get full text
Journal Article -
7
Prevention of Alzheimer's disease: Omega-3 fatty acid and phenolic anti-oxidant interventions
Published in Neurobiology of aging (01-12-2005)“…Alzheimer's disease (AD) and cardiovascular disease (CVD) are syndromes of aging that share analogous lesions and risk factors, involving lipoproteins,…”
Get full text
Journal Article Conference Proceeding -
8
C-terminal part of alpha-synuclein mediates its activity in promoting proliferation of dopaminergic cells
Published in Molecular neurodegeneration (07-02-2012)“…α-Syn has been shown to exhibit a MAP-like activity and promote the assembly of microtubules. Since microtubules play a pivotal role in proliferative cell…”
Get full text
Journal Article -
9
Clinical development of curcumin in neurodegenerative disease
Published in Expert review of neurotherapeutics (01-06-2015)“…Curcumin, a polyphenolic antioxidant derived from the turmeric root has undergone extensive preclinical development, showing remarkable efficacy in wound…”
Get more information
Journal Article -
10
P4–048: Loss of tau function leads to cognitive deficits and synapse loss with aging
Published in Alzheimer's & dementia (01-07-2013)Get full text
Journal Article -
11
Loss of tau function leads to cognitive deficits and synapse loss with aging
Published in Alzheimer's & dementia (01-07-2013)Get full text
Journal Article -
12
O2‐05‐01: Impact of diet and exercise on the development of tau pathology
Published in Alzheimer's & dementia (01-07-2012)Get full text
Journal Article -
13
Impact of diet and exercise on the development of tau pathology
Published in Alzheimer's & dementia (01-07-2012)Get full text
Journal Article -
14
Late-stage intervention with curcumin reduces soluble tau oligomers and corrects cognitive and synaptic deficits
Published in Alzheimer's & dementia (01-07-2011)Get full text
Journal Article -
15
O2‐05‐05: Late‐stage intervention with curcumin reduces soluble tau oligomers and corrects cognitive and synaptic deficits
Published in Alzheimer's & dementia (01-07-2011)Get full text
Journal Article -
16
P4‐077: Loss of Tau Function Causes Synaptic and Cognitive Deficits Resembling AD: Correction With Late Intervention Treatment
Published in Alzheimer's & dementia (01-07-2010)Get full text
Journal Article -
17
P2‐330: Protection of excitatory synapses by DHA through preserving function of NMDA‐Tiam1‐PAK signal pathway in Alzheimer models
Published in Alzheimer's & dementia (01-07-2010)Get full text
Journal Article -
18
Loss of Tau Function Causes Synaptic and Cognitive Deficits Resembling AD: Correction With Late Intervention Treatment
Published in Alzheimer's & dementia (01-07-2010)Get full text
Journal Article -
19
Protection of excitatory synapses by DHA through preserving function of NMDA-Tiam1-PAK signal pathway in Alzheimer models
Published in Alzheimer's & dementia (01-07-2010)Get full text
Journal Article -
20
O1-02-08: DHA, amyloid, GSK3β, trophic signaling and AD prevention
Published in Alzheimer's & dementia (01-07-2007)Get full text
Journal Article